An Intron 4 VNTR Polymorphism of the Endothelial Nitric Oxide Synthase Gene is Associated with Early-onset Colorectal Cancer

Overview

Journal Int J Cancer

Specialty Oncology

Date 2008 Dec 31

PMID 19115208

Citations 16

Authors

Chih-Ching Yeh

Regina M Santella

Ling-Ling Hsieh

Fung-Chang Sung

Reiping Tang

Affiliations

Soon will be listed here.

Abstract

Endothelial-derived nitric oxide, which is produced by endothelial nitric oxide synthase (eNOS), may play an important role in colorectal carcinogenesis. However, the putative contribution of common eNOS genetic polymorphisms to colorectal cancer risk remains unknown. We genotyped 3 polymorphisms of eNOS (T-786C, G894T, and intron4b/a) in 727 colorectal adenocarcinoma cases and 736 age- and sex-matched healthy controls in Taiwan. Genotypes of the T-786C and G894T polymorphisms were determined by fluorescence polarization assays and the 27-bp variable number of tandem repeat (VNTR) polymorphism in intron 4 (intron4b/a) was analyzed by PCR. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Among younger participants (< or =60 yrs), the intron4a variant genotype was associated with a significantly increased risk of colorectal cancer, compared with the intron4bb genotype (OR = 1.60, 95% CI = 1.04-2.46). In addition, those young individuals bearing a greater number of high-risk genotypes (OR > 1, i.e., CT+TT for T-786C, ba+aa for intron4b/a, and GG for G894T) of eNOS had a higher colorectal cancer risk (p(trend) = 0.039). Compared with younger individuals without any putative high-risk genotypes, those with 3 high-risk genotypes had a significantly greater cancer risk (OR = 1.89, 95% CI = 1.04-3.43). Our results suggest that the eNOS intron4b/a polymorphism may contribute to early-onset colorectal cancer risk in the Taiwanese population.

Citing Articles

Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component.

de Melo I, Tavares V, Pereira D, Medeiros R Curr Issues Mol Biol. 2024; 46(5):4845-4873.

PMID: 38785560 PMC: 11120512. DOI: 10.3390/cimb46050292.

Patients with Invasive Tumors and Gene Polymorphisms with Subarachnoid Hemorrhage Tend to Have Poorer Prognosis.

Siroya H, Devi B, Aripirala P, Ramesh S, Bhat D, Shukla D Asian J Neurosurg. 2022; 17(2):199-208.

PMID: 36120623 PMC: 9473864. DOI: 10.1055/s-0042-1750784.

Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review).

Salihi A, Al-Naqshabandi M, Khudhur Z, Housein Z, Hama H, Abdullah R Mol Med Rep. 2022; 26(1).

PMID: 35616143 PMC: 9178674. DOI: 10.3892/mmr.2022.12749.

In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients.

Housein Z, Kareem T, Salihi A Sci Rep. 2021; 11(1):2536.

PMID: 33510426 PMC: 7843626. DOI: 10.1038/s41598-021-82244-x.

The genetic association between and polymorphisms and gastric cancer risk: a meta-analysis.

Zhu Y, Jiang H, Chen Z, Lu B, Li J, Peng Y Onco Targets Ther. 2018; 11:2497-2507.

PMID: 29765229 PMC: 5939909. DOI: 10.2147/OTT.S161925.

References

Schneider B, Radovich M, Sledge G, Robarge J, Li L, Storniolo A . Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res Treat. 2007; 111(1):157-63. DOI: 10.1007/s10549-007-9755-9. View

Thomsen L, Lawton F, Knowles R, Beesley J, Moncada S . Nitric oxide synthase activity in human gynecological cancer. Cancer Res. 1994; 54(5):1352-4. View

Chaves Conde M, Ramirez-Lorca R, Esteban Lopez-Jamar J, Molero E, Ramirez-Armengol J, Moreno Nogueira J . Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep. 2006; 16(2):353-9. View

Xu W, Liu L, Loizidou M, Ahmed M, Charles I . The role of nitric oxide in cancer. Cell Res. 2003; 12(5-6):311-20. DOI: 10.1038/sj.cr.7290133. View

Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H . T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999; 99(22):2864-70. DOI: 10.1161/01.cir.99.22.2864. View

Welfare M, Monesola Adeokun A, Bassendine M, Daly A . Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8(4 Pt 1):289-92. View

Breslow N, Day N . Statistical methods in cancer research. Volume I - The analysis of case-control studies. IARC Sci Publ. 1980; (32):5-338. View

Cheon K, Choi K, Lee H, Park S, Rhee Y, Lee Y . Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung. 2001; 178(6):351-60. DOI: 10.1007/s004080000039. View

Freedman B, Yu H, Anderson P, Roh B, Rich S, Bowden D . Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant. 2000; 15(11):1794-800. DOI: 10.1093/ndt/15.11.1794. View

10.

Kong L, DUNN G, Keefer L, Korthuis R . Nitric oxide reduces tumor cell adhesion to isolated rat postcapillary venules. Clin Exp Metastasis. 1996; 14(4):335-43. DOI: 10.1007/BF00123392. View

11.

Weiner C, Lizasoain I, Baylis S, Knowles R, Charles I, Moncada S . Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994; 91(11):5212-6. PMC: 43962. DOI: 10.1073/pnas.91.11.5212. View

12.

Kwok P . SNP genotyping with fluorescence polarization detection. Hum Mutat. 2002; 19(4):315-23. DOI: 10.1002/humu.10058. View

13.

Yu J, Cui L, Zhang Q, Chen H, Ji P, Wei H . Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol. 2006; 12(29):4660-4. PMC: 4087830. DOI: 10.3748/wjg.v12.i29.4660. View

14.

Wang S, Davis S, Cerhan J, Hartge P, Severson R, Cozen W . Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis. 2006; 27(9):1828-34. DOI: 10.1093/carcin/bgl013. View

15.

Jadeski L, Chakraborty C, Lala P . Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer. 2003; 106(4):496-504. DOI: 10.1002/ijc.11268. View

16.

Medeiros R, Morais A, Vasconcelos A, Costa S, Carrilho S, Oliveira J . Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. Cancer Lett. 2002; 189(1):85-90. DOI: 10.1016/s0304-3835(02)00118-0. View

17.

Garcia-Cardena G, Sarrel P, Sessa W, Bender J . 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res. 1997; 81(5):885-92. DOI: 10.1161/01.res.81.5.885. View

18.

Hefler L, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G . Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol. 2002; 86(2):134-7. DOI: 10.1006/gyno.2002.6749. View

19.

Xu W, Liu L, Smith G, Charles L . Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents. Nat Cell Biol. 2000; 2(6):339-45. DOI: 10.1038/35014028. View

20.

Thomsen L, Miles D, Happerfield L, Bobrow L, Knowles R, Moncada S . Nitric oxide synthase activity in human breast cancer. Br J Cancer. 1995; 72(1):41-4. PMC: 2034139. DOI: 10.1038/bjc.1995.274. View